Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages
SARS-CoV-2 continues to evolve under immunologic pressure. A synthesized version of pemivibart, an anti–SARS-CoV-2 monoclonal antibody with recent emergency-use authorization, showed mixed activity against...
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
Neoadjuvant chemotherapy plus durvalumab, followed by adjuvant durvalumab after cystectomy, led to event-free survival superior to that with neoadjuvant chemotherapy followed by cystectomy alone.
The...
Toward Curing More Patients with Bladder Cancer — A New Perioperative Strategy
Over the past decade, the use of immune checkpoint inhibitors and antibody–drug conjugates has led to longer survival in patients with metastatic bladder cancer....
Case 35-2024: A Newborn with Hypoxemia and a Lung Opacity
A full-term infant was admitted to the neonatal intensive care unit for hypoxemic respiratory failure. During the third week, a chest radiograph showed a...
Extensive Tinea Corporis and Tinea Cruris from Trichophyton indotineae
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
